Skip to main content
. 2013 Mar 4;8(3):e57724. doi: 10.1371/journal.pone.0057724

Figure 4. QPCR confirmation of Met and AKT2 amplification.

Figure 4

A. Copy number change analysis of Met in 13 ovarian clear cell adenocarcinoma samples are shown. Four samples (cc1, cc2, cc8, cc13) had a Met/hTERT ratio greater than 1.5. B. Copy number change analysis of Met in 8 ovarian clear cell adenocarcinoma cell lines are shown. Two cell lines (JHOC-5 and JHOC-8) had a Met/hTERT ratio greater than 1.5. C. Copy number change analysis of AKT2 in 13 ovarian clear cell adenocarcinoma samples are shown. Three samples (cc5, cc11, cc13) had an AKT2/hTERT ratio greater than 1.5. D. The qPCR results for the copy number change analysis of AKT2 in 8 ovarian clear cell adenocarcinoma cell lines are shown. Two cell lines (RMG-II and JHOC-8) had a Met/hTERT ratio greater than 1.5.